Drug For Covid

A Turkish company recently launched the first domestic production of a drug to be used in the treatment of COVID-19 patients, the Demiroren news agency reported Friday.

The production has been progressing at the facility of the pharmaceutical company in the Cerkezkoy district of Tekirdag Province, some 150 km from Istanbul, under the surveillance of about 100 scientists.

The drug with hydroxychloroquine sulfate active ingredient is also known as malaria drug, Demiroren noted, saying the Turkish authorities have recently permitted the sale of the drug in the market.

The Turkish company would soon start producing another drug that would include favipiravir as an active ingredient against COVID-19, the agency added.

Citing the management of the company, Demiroren said the scientists would begin working on a vaccine against the novel coronavirus in the upcoming days.

Turkey has so far reported 1,635 new COVID-19 cases and 55 more deaths, bringing the total number of confirmed cases to 144,749 and the death toll to 4,007.

Disclaimer: News Ghana is not responsible for the reportage or opinions of contributors published on the website.

Send your news stories to [email protected] and via WhatsApp on +1-508-812-0505 

Previous article11 terrorists surrender to Nigerian military
Next articleXi calls for more international support for Africa’s COVID-19 fight
Xinhua News Agency, Xinhuanet is an important central news service-oriented website, an important information organ of the central government, and an important platform for building up China's online international communication capacity. Established on November 7, 1997, as an online news provider of the Xinhua News Agency, it was officially named Xinhuanet on March 10, 2000 and began around-the-clock news release with leading online public opinion at home and setting a good image of China abroad as its main task.


Please enter your comment!
Please enter your name here